| Name | 2-Propenamide, N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl]-, (2E) |
|---|---|
| Synonyms |
RGFP966 (E-isomer)
(E,E)-N-(2-Amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide RGFP966 (E)-N-(2-Amino-4-fluorophenyl)-3-[1-[(E)-3-phenylprop-2-enyl]pyrazol-4-yl]prop-2-enamide RGFP966 1396-8 2-Propenamide, N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl]-, (2E) (E,E)-RGFP966 (E)-N-(2-amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide RGFP966 HDAC3 inhibitor ab144819 RGFP-966 RGFP966 Racemate 2-Propenamide (N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl] |
| Description | (E,E)-RGFP966 is a selective and CNS permeable HDAC3 inhibitor that can be used for the research of Huntington’s disease[1]. |
|---|---|
| Related Catalog | |
| Target |
HDAC3[1] |
| References |
| Molecular Formula | C21H19FN4O |
|---|---|
| Molecular Weight | 362.40000 |
| Exact Mass | 362.15400 |
| PSA | 72.94000 |
| LogP | 4.62390 |
| Storage condition | -20°C |